Women with cirrhosis awaiting liver transplantation (LT) experience higher rates of waitlist mortality than men; it is unknown whether practices surrounding delisting for being "too sick" for LT contribute to this disparity beyond death alone. We conducted an analysis of patients listed for LT in the United Network for Organ Sharing/Organ Procurement and Transplantation Network not receiving exception points from May 1, 2007 to July 1, 2014 with a primary outcome of delisting with removal codes of "too sick" or "medically unsuitable." A total of 44 388 patients were included; 4458 were delisted for being "too sick" for LT. Delisting was more frequent in women (11% vs 9%, P < .001). Compared to delisted men, delisted women differed in age (58 vs 57), nonhepatitis C virus listing diagnoses (69% vs 56%), hepatic encephalopathy (36% vs 31%), height (161.9 vs 177.0 cm), private insurance (47% vs 52%), and Karnofsky performance status (60 vs 70) (P < .001 for all). There were no differences in Model for End-Stage Liver Disease including serum sodium and Child Pugh Scores. A competing risk analysis demonstrated that female sex was independently associated with a 10% (confidence interval 2%-18%) higher risk of delisting when accounting for rates of death and transplantation and adjusting for confounders. This study demonstrates a significant disparity in delisting practices by sex, highlighting the need for better assessments of sickness, particularly in women.
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CULLARO et AL. total bilirubin, international normalized ratio (INR) , serum creatinine, presence of hepatic encephalopathy, and presence of ascites.
| METHODS

| Covariates
Cutoffs deemed to be implausible were as follows: height <120
and >240 cm, weight <30 and >180 kg, total bilirubin ≤ 0 mg/dL, INR ≤ 0, and creatinine ≤ 0 mg/dL. MELDNa was calculated using the standard formula using a lower limit of 1 for all variables. 8 The lower and upper limits of 6 and 40 were used to mimic standard practice. 
UNOS region of listing was
| Outcomes and censoring
The primary outcome in this study was delisting for being too sick for liver transplantation, defined as reported reason for waitlist removal of "medically unsuitable" or "too sick for transplant" in the UNOS database (removal codes 5 and 13, respectively). We sought to examine the association between sex and being deemed too sick for liver trans- Unadjusted models were used to assess the association of all listed covariates. All covariates with a P < .2 in univariate analysis were considered for inclusion in multivariate models. Those not reaching significance of P < .05 were sequentially eliminated.
Competing risks analysis was used in assessing the association between sex and other covariates with the primary outcome. In this analysis using the Fine-Gray model, removal from the waitlist for being too sick, removal for improvement, death, and transplantation were treated as competing risks. 11 Patients who remained alive on the waitlist at the end of follow-up were conventionally censored at the date of the most recent update of the UNOS registry, because they remained at risk for delisting for being too sick. Adjusted cumulative incidence was also estimated based on the competing risk model. This competing risk analysis was used to assess the influence of sex and other covariates on the likelihood of being delisted for being too sick.
Two-sided P < .05 were considered statistically significant.
Analyses were performed using Stata 13.0 statistical software (College Station, TX). This study was approved by the institutional review board at the University of California, San Francisco. Table 1 . Compared to men, women were older (56 vs 55 years, P < .001) and were on the waitlist for longer (213 vs 175 days, P < .001). They were more likely to have a non-HCV listing diagnosis (70 vs 58%, P < .001) and have hepatic encephalopathy (18% vs 17%, P < .001). Women were less likely to have ascites (37% vs 42%, P < .001) and private insurance (54% vs 58%, P < .001). MELDNa at listing (19 vs 20, P < .001) and at delisting (24 vs 24, P < .001) were clinically similar though statistically lower in women compared to men.
| RESULTS
From
During the follow-up period, more women than men were removed from the waitlist for being too sick for liver transplantation (11% vs 9%; P < .001). There were also statistically significant sex differences in other waitlist outcomes: 3095 (18%) women and 4659 (17%) men died (P < .001); 7284 (43%) women and 13 444 (49%) men received a deceased donor liver transplant (P < .001); 985 (6%) women and 1232 (4%) men improved (P < .001); 3590 (21%) women and 5641 (20%) men remained on the waitlist (P < .001).
To better understand why women were more frequently removed from the waitlist for being too sick, we compared women delisted for being too sick to men delisted for being too sick. Delisted women were significantly older (58 vs 57 years, P < .001), shorter (161.9 vs 177.0 cm, P < .001), had a higher prevalence of non-HCV listing diagnoses (69% vs 56%, P < .001), and had a higher prevalence of hepatic encephalopathy (36% vs 31%, P < .001) than delisted men. Delisted women were less likely to have private insurance (47% vs 52%, P < .001). A greater proportion of delisted women were in the lowest functioning category (KPS 10-40; unable to care for self) when compared to delisted men (26% vs 22%, P < .001). Conversely, a greater proportion of delisted men were in the "normal activity" category (35% vs 30%, P < .001). There were no differences in MELDNa at listing or delisting (19 vs 19, P = .65; 28 vs 27, P = .21). There were no differences in waitlist time by sex (218 vs 228 days, P = .20) ( Table 2 ). There were significant differences in the proportion of women delisted by center (P < .001). The difference between delisting MELDNa and listing MELDNa was equal between sexes (5 points vs 4 points, P = .14), suggesting similar rates of hepatic decompensation. The increased cumulative incidence of waitlist removal for being too sick in women is shown in Figure 2 .
A competing risks analysis was completed to determine whether the association between sex and delisting was independent of other variables associated with delisting. In univariate analyses, the follow- Multivariable adjustment for the significant potential confounders did not change the significant association between female sex and delisting for being too sick for liver transplantation; women were 10% more likely to be removed from the waitlist for being too sick for liver transplantation (P < .001) ( Table 3) .
After identifying that women were more frequently removed from the liver transplantation waitlist for being too sick, an analysis was completed to determine whether outcomes after delisting (ie time to death) varied by sex. Of the 4458 patients removed from the waitlist for being too sick, 1355 (30%) died within 30 days of delisting ("early" death). The same proportion of women and men had an "early death" (30% vs 31%, P = .40). There was no difference in length of survival between women who were delisted and men who were delisted (39 vs 46 days, P = .34). Further, among individuals with a KPS score 0-40 (ie, those who were most frail) who underwent liver transplantation, there were no differences in survival after liver transplantation between women and men (852 vs 912 days, P = .14). Despite this, women with a KPS score of 0-40 were disproportionately delisted for being too sick as compared with men with a KPS score of 0-40 (13% vs 10%, P < .001). Those who died within 30 days of delisting had higher rates of HCV (42% vs 38%, P = .01), ascites (60% vs 43%, P < .001), and hepatic encephalopathy (46% vs 28%, P < .001). These patients were more likely to be non-Hispanic and more likely to be in the KPS category "unable to care for self"
(30% vs 22%, P < .001).
| DISCUSSION
While multiple studies have demonstrated sex-based disparities in waitlist mortality, these studies have evaluated only the combined outcome of death and delisting for being too sick for liver transplantation. 2, 4 This is logical, as delisting, for a decompensated cirrhotic patient, essentially translates into near-certain death from end-stage liver disease. However, evaluating this outcome as a combination of the clinical endpoints has not allowed the transplant community to isolate the specific contribution of variable delisting practices to these sex-based disparities. Given that there are no objective or standardized criteria for delisting, this leaves open the possibility that differences in delisting practices for women versus men on the liver transplant waitlist have contributed to these reported disparities.
In this study evaluating rates of delisting from the US liver transplant waitlist, we demonstrate that there are significant sex-based disparities in delisting practices. Women were 10% more likely to be delisted than men. This translated into an absolute difference in the rates of delisting of 2%. Assuming that women and men experience the same rates of hepatic decompensation and death from cirrhosis (outside of the transplant setting), then an additional 692 women were removed from the waitlist than would have been expected had they been men. This disparity persisted despite adjustment for other factors known to be associated with sickness and transplant rates: age, ascites, hepatic encephalopathy, MELDNa score, height, and performance status. These disproportionate delisting practices occurred despite similar survival after delisting.
We offer the following explanations of our results. First, it is possible that women are perceived to be frailer than men. In our study, delisted women were significantly more likely to be in the lowest KPS category, while men were more likely to be in the highest KPS category.
F I G U R E 2 Cumulative incidence of removal from the waitlist for being too sick 
T A B L E 3 Competing risk analysis for delisting for being too sick
This suggests that if perceptions of frailty are impacting delisting, it is having a greater effect on woman than on men, despite no differences in survival after delisting. Second, women are more likely to have longer wait times, due to lower MELD scores, 4 and higher likelihood of declining a liver offer (primarily due to small stature). 12 We propose that this creates a harmful cycle in which women who remain on the waitlist longer have a progressive decline in clinical and functional status and ultimately are more frequently deemed to be "too sick" for liver transplantation. It is our argument that this cycle demonstrates the need for universal, accurate criteria to better capture sickness in patients on the waitlist.
There are limitations to our study. The accuracy of this study is subject to the utilization of appropriate coding in the UNOS registry. There is known variability in removal codes used by OPTN regions. However, by cross-referencing with the Social Security Administration, as done in this study, the variability can be improved. 13 This is imperfect and men may have slightly more frequently misclassified removal codes than women.
14 However, this marginal increase in misclassifying men is unlikely to explain the significant disparities in delisting by sex demonstrated in this study and the disparities demonstrated in other studies looking at waitlist mortality. 2, 4, 12 Next, this study represents a large cohort with the statistical power to make clinically insignificant differences statistically significant. The absolute difference in delisting between men and women in this study represents roughly 97 lives per year. For reference, the use of the MELDNa rather than MELD score corrects roughly 32 patients per year. 8 Therefore, we argue that even a 2% difference has significant clinical implications and efforts should be made to correct this disparity.
Despite these limitations, this is an early study describing the delisting practices in the UNOS registry. There is a clear disparity by sex that persists despite controlling for known confounders. Future studies should focus on the social, behavioral, and non-liver-related factors that lead to more frequent practices of removing women from the waitlist.
